Skip to main content
. Author manuscript; available in PMC: 2017 Jul 27.
Published in final edited form as: Kidney Int. 2016 Sep 22;91(1):86–95. doi: 10.1016/j.kint.2016.07.039

Table 1.

Effect of chronic kidney disease and RAP-011 on mineralizing surfaces

WT Sham = 16 CKD
V = 19		 CKD
R = 20
Mineralizing surface [dLS + (sLS/2)]/BS-% 6.88 11.09a 7.34
Mean ± SE 0.68 1.42 0.98

BS, bone surface; CKD R, CKD+RAP-011; CKD V, CKD mice treated with vehicle; dLS, double-labeled surface; sLS/2, single-labeled surface; WT, wild type.

a

P < 0.01 compared with sham.